PubMed · 9312928
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
J Lund. 1997-09-08. [Generic substitution--unfortunate consequences].. https://pubmed.ncbi.nlm.nih.gov/9312928/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Methylcyclopentadienyl manganese tricarbonyl (MMT) is used as a gasoline octane enhancer. Manganese phosphate is the primary respirable (PM(2.5)) MMT-combustion product emitted from the automobile tailpipe. The goal of this study was to determine the exposure-response relationship for inhaled manganese phosphate in adult male CD rats. Rats were exposed 6-h/day for either 5 days/week (10 exposures) or 7 days/week (14 exposures) to manganese phosphate at 0, 0.03, 0.3, or 3 mg Mn/m(3) (MMAD congruent with 1.5 micrometer). The following tissues collected at the end of the 2-week exposure: plasma, erythrocytes, olfactory bulb, striatum, cerebellum, lung, liver, femur, and skeletal muscle (n = 6 rats/exposure group) were analyzed for manganese content by neutron activation analysis. Intravenous (54)MnCl(2) tracer studies were also conducted following the 14th exposure (n = 6 rats/concentration), and whole-body gamma spectrometry was performed immediately after injection and at 1, 2, 4, 8, 12, and 16 weeks after (54)MnCl(2) administration. Increased manganese concentrations were observed in olfactory bulb, lung, femur, and skeletal muscle following exposure to 3 mg Mn/m(3) (10 or 14 exposures). Increased manganese concentrations were also observed in olfactory bulb, striatum, and lung following exposure to 0.3 mg Mn/m(3) (14 exposures only). Red blood cell and plasma manganese concentrations were increased only in rats exposed to 3 mg Mn/m(3) (10 exposures). Rats exposed to 3 mg Mn/m(3) also had an increased whole-body manganese clearance rate when compared to air-exposed control animals. Our results suggest that the rat olfactory bulb may accumulate more manganese than other brain regions following inhalation exposure.
This investigation sought to determine the effect of cadmium (Cd) aerosol exposure on the pulmonary expression of the heavy subunit (HS) of gamma-glutamylcysteine synthetase (gamma-GCS), the rate-limiting enzyme in de novo synthesis of glutathione (GSH). Using Northern hybridization analysis, we demonstrated that CdO inhalation caused time- and dose-dependent increases in the steady-state levels of gamma-GCS-HS mRNA that were highly correlated with lung Cd burden. Observed increases in gamma-GCS-HS gene expression were maximal 2 h following a single aerosol exposure to Cd and appeared to be triggered by an oxidant stress, characterized by a decline in the reduced to oxidized glutathione ratio. Immunoblotting of proteins in lung extracts from treated and untreated animals produced a single protein band corresponding to a molecular weight of 73 kDa. Elevated levels of gamma-GCS-HS mRNA and gamma-GCS-HS protein in lungs of Cd-exposed animals were also accompanied by higher gamma-GCS enzymatic activity and elevations in glutathione (GSH). Immunohistochemical and in situ hybridization studies were used to identify compartments in the lung where Cd-induced expression of gamma-GCS-HS was localized. The most prominent staining for gamma-GCS-HS protein and gamma-GCS-HS mRNA was observed in the alveolar epithelium of Cd-exposed animals. Quantitative image analysis confirmed a good agreement between relative levels of protein and mRNA transcripts for gamma-GCS-HS. These observations suggest that resistance to Cd toxicity in the lung may reflect the ability of specific lung cells to upregulate gamma-GCS expression and increase de novo GSH synthesis as an adaptive response.
BACKGROUND: More than one dose of measles vaccine is necessary for the sustained control of measles. The aerosol route is thought to be more immunogenic for booster doses than traditional subcutaneous injections, so we did a randomised comparative trial of aerosol and subcutaneous measles vaccines in South African schoolchildren. METHODS: 4327 schoolchildren (aged 5-14 years), assigned by block randomisation of classrooms, received standard titre doses of either Schwarz or Edmonston-Zagreb measles vaccines subcutaneously or by aerosol. Blood samples for antibody assay were collected before vaccination, at 1 month, and 1 year after vaccination. The main endpoints (antibody titres at 1 month and 1 year) were compared between groups. FINDINGS: 992 children had antibody titre data available for all timepoints. 14 (3.6%) of 385 children who received Edmonston-Zagreb vaccine by aerosol were seronegative 1 year after vaccination, compared with 28 (8.6%) of 326 children who received Edmonston-Zagreb subcutaneous vaccine and 39 (13.9%) of 281 children who received Schwarz subcutaneous vaccine. At 1 month, 326 (84.7%) children who received aerosol Edmonston-Zagreb vaccine had seroconverted, compared with 257 (78.8%) who received subcutaneous Edmonston-Zagreb vaccine and 176 (62.6%) who received subcutaneous Schwarz vaccine. At 1 month, only 116 (22.7%) of 511 children in the Schwarz aerosol group had seroconverted; this aerosol vaccine had no detectable potency after 2 min of nebulisation. There were no serious side-effects: about 5% of children in each group had a rash within 2 weeks of vaccination. INTERPRETATION: An aerosol vaccination method that uses currently available devices and a suitably stable vaccine is effective and acceptable. This form of delivery is adaptable to mass campaigns, avoids the risks associated with injections, and could help measles eradication.